Location History:
- Foster City, CA (US) (2001)
- Redwood City, CA (US) (2002 - 2008)
Company Filing History:
Years Active: 2001-2008
Title: The Innovative Contributions of Sarma Duddu
Introduction
Sarma Duddu is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and methods involving amphotericin B and other compounds. With a total of 3 patents to his name, Duddu's work has the potential to impact various medical treatments.
Latest Patents
Duddu's latest patents include innovative compositions comprising amphotericin B. One of his notable inventions is a composition that includes particles with at least about 95 wt % of amphotericin B, where the particles have a mass median diameter ranging from about 1.1 µm to about 1.9 µm. Another composition also features particles with at least about 95 wt % of amphotericin B, with at least about 80 wt % of the particles having a geometric diameter within the same range. Additionally, he has developed a composition where the particles have a mass median diameter of less than about 1.9 µm, and the amphotericin B exhibits a crystallinity level of at least about 20%. His work also includes a patent for Eprosartan dihydrate, which relates to a compound used to block angiotensin II receptors, aiding in the treatment of hypertension, congestive heart failure, and renal failure.
Career Highlights
Throughout his career, Sarma Duddu has worked with prominent companies such as SmithKline Beecham Corporation and Nektar Therapeutics. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.
Collaborations
Duddu has collaborated with several professionals in his field, including Nageswara R Palepu and Gopadi M Venkatesh. These collaborations have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Sarma Duddu's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work on compositions involving amphotericin B and other compounds showcases the potential for significant advancements in treatment options.